title: Initial assessment of the beneficial effect of partial splenectomy in hereditary spherocytosis.
abstract: Clinical manifestations of hereditary spherocytosis (HS), the most common red blood cell (RBC) membrane disorder, can be abrogated or markedly reduced by splenectomy. However, concerns regarding risks from overwhelming infections after splenectomy have restricted its use, especially in children. This study was designed to determine if partial splenectomy can decrease the hemolytic rate while maintaining phagocytic function of the spleen. Partial splenectomy was performed in 11 children (age 2 to 13) with HS. The effect on hemolytic rate was assessed by comparing the presurgical and postsurgical values for hemoglobin, reticulocyte number, and RBC life span. The residual splenic phagocytic function was assessed using technetium 99m scans and by enumerating the percentage of pitted RBCs in circulation. There were no complications from the surgical procedure in any of the 11 individuals. Following partial splenectomy, hemoglobin increased on the average by 3 g/dL, reticulocyte count decreased by 300 x 10(6)/L, and RBC life span was substantially prolonged. Normal technetium uptake was noted in the splenic remnant and the percentage of pitted RBCs was in the normal range. Partial splenectomy is effective in decreasing the hemolytic rate while maintaining residual splenic phagocytic function of the spleen in HS. We conclude that the use of this procedure as treatment for RBC membrane disorders warrants consideration, especially in infants under 5 years of age who need frequent transfusions.
authors: Laboratoire d'Hematologie, Hopital Bicetre, Kremlin Bicetre, France.
authors: G
authors: G
authors: Tchernia
authors: F
authors: F
authors: Gauthier
authors: F
authors: F
authors: Mielot
authors: J P
authors: JP
authors: Dommergues
authors: J
authors: J
authors: Yvart
authors: J A
authors: JA
authors: Chasis
authors: N
authors: N
authors: Mohandas
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004905:Erythrocyte Aging; D006461:Hemolysis; D006801:Humans; D010587:Phagocytosis; D011788:Quality of Life; D013103:Spherocytosis, Hereditary / Q000097:blood / Q000503:physiopathology / Q000601:surgery*; D013154:Spleen / Q000503:physiopathology; D013156:Splenectomy